Nexo Therapeutics, Inc.

Amendment

CIK: 0001955319·Biotechnology·DELAWARE·Filed: Mar 27, 2026

Total Offering

$60,000,000

Amount Sold

$60,000,000

Investors

7

First Sale

Nov 15, 2022

Offering Details

Type: Equity, Debt
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
Andrew Phillips	Related Person
Ali Behbahani	Related Person
Carlo Rizzuto	Related Person

Company

Nexo Therapeutics, Inc.

11757 W. KEN CARYL AVENUE

LITTLETON, CO, 80127-3719

303-868-6790

SEC Filing

0001955319-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.